Assessment of p.Phe508del-CFTR functional restoration in pediatric primary cystic fibrosis airway epithelial cells

Background Mutations in the cystic fibrosis transmembrane regulator (CFTR) gene can reduce function of the CFTR ion channel activity and impair cellular chloride secretion. The gold standard method to assess CFTR function of ion transport using the Ussing chamber requires a high number of airway epithelial cells grown at air-liquid interface, limiting the application of this method for high throughput screening of potential therapeutic compounds in primary airway epithelial cells (pAECs) featuring less common CFTR mutations. This study assessed an alternative approach, using a small scale halide assay that can be adapted for a personalized high throughput setting to analyze CFTR function of pAEC. Methods Pediatric pAECs derived from children with CF (pAECCF) were established and expanded as monolayer cultures, before seeding into 96-well plates for the halide assay. Cells were then transduced with an adenoviral construct containing yellow fluorescent protein (eYFP) reporter gene, alone or in combination with either wild-type CFTR (WT-CFTR) or p.Phe508del CFTR. Four days post transduction, cells were stimulated with forskolin and genistein, and assessed for quenching of the eYFP signal following injection of iodide solution into the assay media. Results Data showed that pAECCF can express eYFP at high efficiency following transduction with the eYFP construct. The halide assay was able to discriminate functional restoration of CFTR in pAECCF treated with either WT-CFTR construct or the positive controls syntaxin 8 and B-cell receptor-associated protein 31 shRNAs. Significance The current study demonstrates that the halide assay can be adapted for pediatric pAECCF to evaluate restoration of CFTR function. With the ongoing development of small molecules to modulate the folding and/or activity of various mutated CFTR proteins, this halide assay presents a small-scale personalized screening platform that could assess therapeutic potential of molecules across a broad range of CFTR mutations.

[1]  J. Rommens,et al.  Phenotypic profiling of CFTR modulators in patient-derived respiratory epithelia , 2017, npj Genomic Medicine.

[2]  Ashley M. Jacobi,et al.  SYVN1, NEDD8, and FBXO2 Proteins Regulate ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Ubiquitin-mediated Proteasomal Degradation* , 2016, The Journal of Biological Chemistry.

[3]  P. de Coppi,et al.  Rapid Expansion of Human Epithelial Stem Cells Suitable for Airway Tissue Engineering. , 2016, American journal of respiratory and critical care medicine.

[4]  M. Hild,et al.  Production of 3-D Airway Organoids From Primary Human Airway Basal Cells and Their Use in High-Throughput Screening. , 2016, Current protocols in stem cell biology.

[5]  H. Janssens,et al.  Optimal correction of distinct CFTR folding mutants in rectal cystic fibrosis organoids , 2016, European Respiratory Journal.

[6]  T. Rich,et al.  Overcoming limitations of FRET measurements , 2016, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[7]  G. Lukács,et al.  Potentiators of Defective ΔF508–CFTR Gating that Do Not Interfere with Corrector Action , 2015, Molecular Pharmacology.

[8]  N. Dokholyan,et al.  Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis , 2014, Science Translational Medicine.

[9]  H. D. de Jonge,et al.  Cystic fibrosis: toward personalized therapies. , 2014, The international journal of biochemistry & cell biology.

[10]  F. Gage,et al.  Generation of multiciliated cells in functional airway epithelia from human induced pluripotent stem cells , 2014, Proceedings of the National Academy of Sciences.

[11]  Hans Clevers,et al.  Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. , 2013, Cell stem cell.

[12]  P. Sivashanmugam,et al.  A Rapid Membrane Potential Assay to Monitor CFTR Function and Inhibition , 2013, Journal of biomolecular screening.

[13]  J. Rossant,et al.  Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFTR protein , 2012, Nature Biotechnology.

[14]  Chad A. Cowan,et al.  Generation of multipotent lung and airway progenitors from mouse ESCs and patient-specific cystic fibrosis iPSCs. , 2012, Cell stem cell.

[15]  E. Sutanto,et al.  Innate inflammatory responses of pediatric cystic fibrosis airway epithelial cells: effects of nonviral and viral stimulation. , 2011, American journal of respiratory cell and molecular biology.

[16]  J. Gustafson,et al.  Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.

[17]  Leatrice N Vogel,et al.  CFTR Delivery to 25% of Surface Epithelial Cells Restores Normal Rates of Mucus Transport to Human Cystic Fibrosis Airway Epithelium , 2009, PLoS biology.

[18]  P. Negulescu,et al.  Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770 , 2009, Proceedings of the National Academy of Sciences.

[19]  E. Sutanto,et al.  Comparison of techniques for obtaining lower airway epithelial cells from children , 2008, European Respiratory Journal.

[20]  A. Bush,et al.  Cystic fibrosis , 2007, BMJ : British Medical Journal.

[21]  M. Lusky,et al.  Cellular localization and activity of Ad-delivered GFP-CFTR in airway epithelial and tracheal cells. , 2007, American Journal of Respiratory Cell and Molecular Biology.

[22]  E. Sutanto,et al.  Intrinsic biochemical and functional differences in bronchial epithelial cells of children with asthma. , 2006, American journal of respiratory and critical care medicine.

[23]  James Rader,et al.  Rescue of DeltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[24]  R. Loi,et al.  Limited restoration of cystic fibrosis lung epithelium in vivo with adult bone marrow-derived cells. , 2006, American journal of respiratory and critical care medicine.

[25]  Kai Du,et al.  Small-molecule correctors of defective DeltaF508-CFTR cellular processing identified by high-throughput screening. , 2005, The Journal of clinical investigation.

[26]  D. Knight,et al.  The use of non-bronchoscopic brushings to study the paediatric airway , 2005, Respiratory research.

[27]  D. Prockop,et al.  Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: potential therapy for cystic fibrosis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[28]  R. Dérand,et al.  Syntaxin 8 impairs trafficking of cystic fibrosis transmembrane conductance regulator (CFTR) and inhibits its channel activity , 2004, Journal of Cell Science.

[29]  T. Ma,et al.  Nanomolar Affinity Small Molecule Correctors of Defective ΔF508-CFTR Chloride Channel Gating* , 2003, Journal of Biological Chemistry.

[30]  Seng H. Cheng,et al.  Partial correction of defective Cl(-) secretion in cystic fibrosis epithelial cells by an analog of squalamine. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[31]  L. Galietta,et al.  Cell-based assay for high-throughput quantitative screening of CFTR chloride transport agonists. , 2001, American journal of physiology. Cell physiology.

[32]  I. Doull.  Recent advances in cystic fibrosis , 2001, Archives of disease in childhood.

[33]  A S Verkman,et al.  Green fluorescent protein‐based halide indicators with improved chloride and iodide affinities , 2001, FEBS letters.

[34]  M. Reth,et al.  Control of Cystic Fibrosis Transmembrane Conductance Regulator Expression by BAP31* , 2001, The Journal of Biological Chemistry.

[35]  S J Remington,et al.  Mechanism and Cellular Applications of a Green Fluorescent Protein-based Halide Sensor* , 2000, The Journal of Biological Chemistry.

[36]  A. Verkman,et al.  Long-wavelength iodide-sensitive fluorescent indicators for measurement of functional CFTR expression in cells. , 1999, American journal of physiology. Cell physiology.

[37]  M. Morales,et al.  Structure and function of the cystic fibrosis transmembrane conductance regulator. , 1999, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[38]  A. Verkman,et al.  Fluorescent chloride indicators to assess the efficacy of CFTR cDNA delivery. , 1999, Human gene therapy.

[39]  Matthew P. Anderson,et al.  Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive , 1992, Nature.

[40]  A. Verkman.  Development and biological applications of chloride-sensitive fluorescent indicators. , 1990, The American journal of physiology.

[41]  Q. Tan,et al.  Human airway organoid engineering as a step toward lung regeneration and disease modeling. , 2017, Biomaterials.

[42]  J. Elborn,et al.  Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR. , 2015, The New England journal of medicine.

[43]  J. Rhim,et al.  Epithelial and Mesenchymal Cell Biology ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells , 2012 .

[44]  R. Kopito,et al.  Biosynthesis and degradation of CFTR. , 1999, Physiological reviews.

[45]  James M. Wilson,et al.  Submucosal glands are the predominant site of CFTR expression in the human bronchus , 1992, Nature Genetics.

[46]  Edinburgh Research Explorer Measurement of halide efflux from cultured and primary airway epithelial cells using fluorescence indicators , 2022 .